Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of RRM2 mRNA | increases expression | 20713471
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of RRM2 mRNA | increases expression | 18648102
|
D000082 |
Acetaminophen |
Acetaminophen results in decreased expression of RRM2 mRNA | decreases expression | 17942131
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of RRM2 protein | affects expression | 20106945
|
D000968 |
Antimycin A |
Antimycin A results in decreased expression of RRM2 mRNA | decreases expression | 19304788
|
D001374 |
Azacitidine |
[Azacitidine co-treated with Thalidomide] affects the expression of RRM2 mRNA | affects cotreatment|affects expression | 18720364
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of RRM2 mRNA | decreases expression | 20106945 20064835
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of RRM2 mRNA | decreases expression | 17942131
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RRM2 mRNA | decreases expression | 20382639
|
C053541 |
bicalutamide |
bicalutamide results in decreased expression of RRM2 mRNA | decreases expression | 15638997
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of RRM2 mRNA | increases expression | 16474171
|
C005961 |
bis(tri-n-butyltin)oxide |
bis(tri-n-butyltin)oxide results in decreased expression of RRM2 mRNA | decreases expression | 17942131
|
D019256 |
Cadmium Chloride |
Cadmium Chloride results in decreased expression of RRM2 mRNA | decreases expression | 17961207
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of RRM2 mRNA | affects expression | 17484886
|
D003520 |
Cyclophosphamide |
RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of RRM2 mRNA | decreases expression | 20106945
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of RRM2 mRNA | decreases expression | 17942131
|
D003561 |
Cytarabine |
Cytarabine results in increased expression of RRM2 mRNA | increases expression | 19194470
|
C020735 |
dibutyldichlorotin |
dibutyldichlorotin results in increased expression of RRM2 mRNA | increases expression | 10722888
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of RRM2 mRNA | increases expression | 18042831
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of RRM2 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of RRM2 mRNA | increases expression | 19638242
|
D004317 |
Doxorubicin |
Doxorubicin affects the expression of RRM2 mRNA | affects expression | 15205334
|
D004317 |
Doxorubicin |
RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D004958 |
Estradiol |
Estradiol results in decreased expression of RRM2 mRNA | decreases expression | 20106945
|
D004958 |
Estradiol |
Estradiol results in increased expression of RRM2 mRNA | increases expression | 16474171
|
D004958 |
Estradiol |
[Progesterone co-treated with Estradiol] results in decreased expression of RRM2 mRNA | affects cotreatment|decreases expression | 17404688
|
D004958 |
Estradiol |
Estradiol affects the expression of RRM2 mRNA | affects expression | 15598610
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of RRM2 mRNA | affects expression | 17351261
|
D005472 |
Fluorouracil |
Fluorouracil affects the expression of RRM2 mRNA | affects expression | 15205334 16584549
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of RRM2 mRNA | decreases expression | 17039268 16557594
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of RRM2 mRNA | increases expression | 16709241
|
D005472 |
Fluorouracil |
RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
D005472 |
Fluorouracil |
RRM2 protein affects the susceptibility to Fluorouracil | affects response to substance | 15548681
|
C106014 |
gedunin |
gedunin results in decreased expression of RRM2 mRNA | decreases expression | 17010675
|
D019833 |
Genistein |
Genistein results in increased expression of RRM2 mRNA | increases expression | 16474171
|
D007501 |
Iron |
[Iron co-treated with Oxygen] binds to RRM2 protein | affects binding|affects cotreatment | 16829694
|
C015329 |
lycopene |
lycopene results in increased expression of RRM2 mRNA | increases expression | 16886892
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of RRM2 mRNA | increases expression | 20713471
|
C008493 |
methylselenic acid |
methylselenic acid affects the expression of RRM2 mRNA | affects expression | 14617803
|
D010100 |
Oxygen |
[Iron co-treated with Oxygen] binds to RRM2 protein | affects binding|affects cotreatment | 16829694
|
D010126 |
Ozone |
Ozone results in increased expression of RRM2 mRNA | increases expression | 19555225
|
D017239 |
Paclitaxel |
RRM2 mRNA affects the susceptibility to [Paclitaxel co-treated with Fluorouracil co-treated with Doxorubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 16896004
|
C041786 |
palm oil |
palm oil results in increased expression of RRM2 mRNA | increases expression | 18042831
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of RRM2 mRNA | increases expression | 17560707
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of RRM2 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of RRM2 mRNA | increases expression | 19482888
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of RRM2 mRNA | increases expression | 18445702 18301758
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in increased expression of RRM2 mRNA | increases expression | 16474171
|
D011374 |
Progesterone |
[Progesterone co-treated with Estradiol] results in decreased expression of RRM2 mRNA | affects cotreatment|decreases expression | 17404688
|
D011374 |
Progesterone |
Progesterone results in increased expression of RRM2 mRNA | increases expression | 18070364
|
C059514 |
resveratrol |
resveratrol results in decreased expression of RRM2 mRNA | decreases expression | 15767336
|
D012402 |
Rotenone |
Rotenone results in decreased expression of RRM2 mRNA | decreases expression | 19304788
|
D012402 |
Rotenone |
Rotenone results in increased expression of RRM2 mRNA | increases expression | 19013527
|
C025462 |
sulindac sulfide |
sulindac sulfide results in decreased expression of RRM2 mRNA | decreases expression | 12734198
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of RRM2 mRNA | decreases expression | 16714409
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RRM2 mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of RRM2 mRNA | increases expression | 15667827 19465110
|
D013792 |
Thalidomide |
[Azacitidine co-treated with Thalidomide] affects the expression of RRM2 mRNA | affects cotreatment|affects expression | 18720364
|
D024505 |
Tocopherols |
Tocopherols results in increased expression of RRM2 mRNA | increases expression | 17056531
|
C496197 |
trans-10,cis-12-conjugated linoleic acid |
trans-10,cis-12-conjugated linoleic acid results in decreased expression of RRM2 mRNA | decreases expression | 17951470
|
C050414 |
tripterine |
tripterine results in decreased expression of RRM2 mRNA | decreases expression | 17010675
|
D014635 |
Valproic Acid |
Valproic Acid results in decreased expression of RRM2 mRNA | decreases expression | 19101580
|
D014747 |
Vinblastine |
RRM2 protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
16.23 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
16.23 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Thalidomide |
16.23 | 8333272 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
16.23 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.47 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.42 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.40 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
7.67 | 16759491 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
7.67 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
15.07 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
15.07 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
15.07 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
15.07 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
15.07 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
15.07 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
17.72 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
17.72 | 6695378 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
17.72 | 6695378 10737359 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
17.72 | 6695378 10545420 |
MESH:D000236 |
Adenoma |
|
resveratrol |
17.72 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
20.69 | 18056438 19061943 17162532 17620307 16434500 19052882 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
20.69 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
20.69 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
20.69 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.06 | 21441931 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
5.14 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
8.33 | 16563566 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
8.33 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
8.33 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
sulindac sulfide |
8.33 | 18759972 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.71 | 17688650 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Thalidomide |
4.03 | 16510725 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
12.34 | 15504547 16511603 17963324 |
MESH:D000740 |
Anemia |
|
Iron |
12.34 | 16566752 16434484 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
12.34 | 11748828 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
4.21 | 16569441 17163184 17375513 17162259 17147795 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
4.36 | 16910769 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.33 | 10982225 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.55 | 20872349 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.17 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.58 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
3.93 | 16604332 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
14.20 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
14.20 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
14.20 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
10.53 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
10.53 | 17115116 |
MESH:D001169 |
Arthritis, Experimental |
|
Thalidomide |
10.53 | 9598899 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.42 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.47 | 17854713 16373670 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
4.94 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
13.14 | 16640825 16632123 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
13.14 | 11922910 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
13.14 | 16391483 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
13.14 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.10 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.10 | 17352947 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.10 | 17688650 20603192 19460635 15238991 18985861 18316065 18177632 17507914 18775368 18558336 17157402 18396377 18940202 16609825 19232924 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.69 | 16640825 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.50 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.80 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.26 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.26 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.27 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
6.90 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
6.90 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.18 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.10 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.41 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.82 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.76 | 15665606 15380490 15845082 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.78 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.37 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
14.74 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
14.74 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
14.74 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
14.74 | 11325840 15136595 17388661 15093573 18234424 12006526 16978400 17020986 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
14.74 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
14.74 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
14.74 | 16096432 15634643 18234424 15692762 16264153 16826403 18628466 18382427 18695136 16595493 17369602 15993339 19526202 16935488 15939500 15994142 15567936 16115903 17426702 16322301 11325840 17983394 15136595 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
14.74 | 17289903 16675129 17261762 17018787 12948864 14630087 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
14.74 | 19217205 16595493 16110121 16557594 18357371 15136595 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
14.74 | 16541309 17200150 16873071 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
14.74 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
14.74 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
14.74 | 18223236 16273361 11325840 16244791 18234424 15136595 16115903 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
14.74 | 15562024 17614352 16175315 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
14.74 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
14.74 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.28 | 16777450 17626835 15516495 18315731 19059883 18417511 14754758 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.23 | 16183385 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.95 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.29 | 3786805 16227642 16097048 15700767 16192424 16011737 16050911 15673190 10355542 18705752 15721981 16124888 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
10.63 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
10.63 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
11.65 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
11.65 | 10545420 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
11.65 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
marker/mechanism |
|
| 18230555 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
33.04 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
33.04 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
33.04 | 21507988 12907637 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
33.04 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
33.04 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
33.04 | 16681979 20007298 20514400 19822196 20101231 19171122 10737359 11831363 19208518 3581430 19919837 20935162 17162532 16807293 19701751 17138121 19418558 16288022 20512989 17173139 19107877 16779866 18691550 16698587 10672840 19335982 18393292 19519916 19052882 17428255 19383236 16830150 18665156 17978847 16328049 20524982 18978308 18785209 18788625 18506893 18056438 20084675 18210153 16540662 20727157 21159647 16569478 19394651 19539802 16878318 18971187 16502159 3084413 20432363 18494052 20214788 16935385 17055752 17761372 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
33.04 | 16234567 16023760 17876044 18059187 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
33.04 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
33.04 | 16332177 17088986 17045692 16799960 18930000 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
33.04 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
33.04 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
33.04 | 17173139 1701930 20007298 6705139 20935162 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
33.04 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Thalidomide |
33.04 | 16313753 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.48 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
9.80 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
9.80 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
sulindac sulfide |
3.25 | 12391285 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
17.45 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
17.45 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
17.45 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
17.45 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
17.45 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
9.36 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
9.36 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
9.36 | 16280240 16757204 17066447 18986760 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
9.36 | 16227395 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.07 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
7.02 | 15792986 16651473 16109756 16364871 17928571 15476868 17351982 16731534 17382496 17308081 16952015 17519947 16278810 17131338 16612575 17329180 15811867 16269455 17007740 17924179 15505089 18627295 16242529 17974986 16455267 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
7.02 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.52 | 16243910 17334414 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
5.52 | 16604332 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.32 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.32 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.27 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
26.30 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
26.30 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
26.30 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
26.30 | 8243401 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
26.30 | 7505956 17174075 2727394 21159647 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
26.30 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
26.30 | 16192471 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.76 | 4080065 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.51 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
13.72 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
13.72 | 16835633 |
MESH:D018281 |
Cholangiocarcinoma |
|
Thalidomide |
13.72 | 18291259 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
16.08 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
16.08 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
16.08 | 15861022 16919318 16105132 17333356 17110522 17681005 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
16.08 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.87 | 16354765 15668235 8697196 12621046 15340226 |
MESH:D003092 |
Colitis |
|
resveratrol |
8.40 | 16474422 |
MESH:D003092 |
Colitis |
|
Thalidomide |
8.40 | 16680017 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
7.35 | 16510598 17018589 17725105 17172411 15001691 18772588 16340194 17287894 17169374 17016597 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
7.35 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
7.35 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
7.35 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 15814641 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
9.48 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
9.48 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
9.48 | 18509181 18949393 20501625 17255274 16282729 17016601 18448328 15148649 16524972 17401013 17454858 15289873 16303861 14970324 18802399 18383874 16331619 17094418 17695437 18288408 16391804 17594712 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
9.48 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
9.48 | 15531428 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
9.48 | 16550006 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
9.48 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.63 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Thalidomide |
5.07 | 9301478 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.41 | 16507316 |
MESH:D003389 |
Cranial Nerve Diseases |
|
Thalidomide |
5.79 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.52 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Thalidomide |
3.52 | 9200351 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.52 | 17688650 16575769 8888407 |
MESH:D003424 |
Crohn Disease |
|
Thalidomide |
3.90 | 16078585 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.47 | 18093676 15276878 15643279 16413132 16614059 16651033 18433785 18483878 12913760 16989017 17979934 17010015 10498854 12388444 18710439 18295254 11948286 10700343 18372110 12161096 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.28 | 16733453 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.25 | 16140633 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.34 | 8970840 8156756 11298694 12868966 14531868 2524372 11906362 18759878 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.17 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.03 | 3621924 2952479 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
4.03 | 16604332 16640825 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
7.30 | 10990075 11751995 15331540 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
7.30 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
5.36 | 18772604 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
5.36 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
9.00 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
9.00 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
9.00 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
9.00 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
7.60 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
7.60 | 16286809 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.00 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
15.90 | 9022650 16192314 8291058 7440962 11289319 18289764 6482804 1440618 6679447 9653073 9328219 18692083 18648102 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
15.90 | 14725611 12958197 19739265 14986274 16393943 17906064 12594235 19085960 11461765 15968718 11529661 17522070 16781746 15619225 2444490 19420014 19923254 10774834 18713872 16177239 12705907 16109766 19416960 16081117 19370779 16227642 17562736 11421492 10915739 11834606 16485898 11743745 14550746 18071297 19164858 11739529 12153990 11287661 10663392 12392966 12540782 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
15.90 | 4309450 19336974 15027814 7179309 9327722 6884620 17522070 11566570 2869522 3732212 10092053 19085960 21278145 16227642 10915739 7120509 15968718 6623471 3786805 15998439 16177239 7440962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
15.90 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
15.90 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.90 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
15.90 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.58 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.84 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
6.84 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.08 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.32 | 20016425 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
8.88 | 1851702 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
8.88 | 1851702 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
12.77 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
12.77 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
12.77 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.77 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.38 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
12.61 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
12.61 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
12.61 | 17872969 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.08 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
10.52 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
10.52 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
10.52 | 11473722 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.46 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.46 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.64 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.35 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
3.73 | 11006010 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
9.15 | 3659116 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
9.15 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
8.26 | 3922381 11558140 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
8.26 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
5.73 | 20417680 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
5.73 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
7.44 | 6401628 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
7.44 | 6254150 7562514 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
9.65 | 7750514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
9.65 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
8.79 | 3659116 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
8.79 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.60 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.12 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.12 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
12.12 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
12.12 | 16785472 16481741 15173087 16337965 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
12.12 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.63 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
35.37 | 16239168 12631006 16045604 19224547 17595544 61145 15959796 12795759 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
35.37 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
35.37 | 17967931 19551842 18296743 19004024 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
35.37 | 20387270 21071580 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
35.37 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Iron |
35.37 | 16640825 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
35.37 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
35.37 | 14986274 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.96 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.37 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.65 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.50 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.08 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.43 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
17.08 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
17.08 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
17.08 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
17.08 | 20067830 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
4.93 | 16640825 16604332 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
4.70 | 20016425 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.16 | 16983495 |
MESH:D005871 |
Giant Lymph Node Hyperplasia |
|
Thalidomide |
5.79 | 12701121 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.71 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
6.20 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
6.20 | 16598420 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
5.71 | 16145905 |
MESH:D005910 |
Glioma |
|
Thalidomide |
5.71 | 16327979 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.00 | 11389073 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.57 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.08 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.54 | 11014644 16376943 15172196 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
6.74 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
6.74 | 18337622 15102660 15162350 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.49 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.49 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.13 | 18674790 16707910 16879835 18006777 14766674 17888722 17875725 16244371 16244372 16495754 16144979 16330681 12587719 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
5.96 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
5.96 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.45 | 15692506 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
4.11 | 17236123 16640825 17255318 17053826 16604332 16574947 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.91 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.79 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.88 | 11000095 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.70 | 16604332 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.02 | 14986274 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
7.63 | 6705139 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
7.63 | 19110552 19900420 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
4.95 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
4.44 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
21.91 | 16890145 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
21.91 | 3609246 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
21.91 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
21.91 | 18467677 19772884 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
21.91 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.51 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.68 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.39 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
14.12 | 16135485 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
14.12 | 16200630 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
14.12 | 18501091 15147373 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
14.12 | 18501091 18180244 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.24 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.36 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.53 | 16354765 15340226 18606429 8697196 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.52 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
6.52 | 12083418 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.02 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
7.71 | 21332399 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
7.71 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.74 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
7.74 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
7.74 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.44 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.22 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.22 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.59 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.86 | 17488730 |
MESH:D007006 |
Hypogonadism |
|
Iron |
4.04 | 16640825 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.31 | 16569931 16945680 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.59 | 16640825 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.81 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
9.84 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
9.84 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.99 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
5.72 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
5.72 | 17937319 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
19.87 | 20412841 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
19.87 | 18785209 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
19.87 | 12083418 |
MESH:D007249 |
Inflammation |
|
Progesterone |
19.87 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
19.87 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
19.87 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Thalidomide |
19.87 | 16134734 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.03 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
14.82 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
14.82 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
14.82 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
14.82 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.57 | 17163184 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.50 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.88 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.92 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
15.78 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
15.78 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
15.78 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
15.78 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
15.78 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
3.70 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
14.36 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
14.36 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
14.36 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
14.36 | 16985049 |
MESH:D007898 |
Leishmaniasis, Visceral |
|
Thalidomide |
3.95 | 16514283 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
9.12 | 19148494 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
9.12 | 10602166 |
MESH:D007938 |
Leukemia |
|
Genistein |
9.12 | 18980019 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.64 | 16085563 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.26 | 17008537 17802794 18172266 17658394 17296974 18587576 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.71 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
4.17 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
5.69 | 17596541 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Thalidomide |
5.69 | 18720364 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
5.69 | 17596541 16294345 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
4.72 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.24 | 16087638 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
4.46 | 10052129 11830472 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
4.93 | 16563566 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
4.72 | 8812269 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Thalidomide |
4.08 | 10473037 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.35 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
22.05 | 17157831 16221502 16943688 16239168 11408273 17174718 21278145 11903743 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
22.05 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
22.05 | 18407596 19638242 18522880 20032147 18665156 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
22.05 | 16640825 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
22.05 | 21047994 |
MESH:D008103 |
Liver Cirrhosis |
|
Thalidomide |
22.05 | 17174718 16943688 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
2.87 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
9.64 | 18705752 18376398 18317297 12666154 16097048 15338365 17565644 17823541 18166357 14512876 14716833 18251166 18472094 15370692 14724832 14620537 15123356 15730626 18187930 17557913 17766677 18395914 15893842 17708605 20821823 14716496 12586293 18006644 17481882 15673190 17976157 13678700 18395095 18418968 15650968 12667390 12649538 15925388 12445418 17721639 15959796 18156304 18339082 18205269 15362042 12546737 18263696 17761835 18054572 15876570 12958196 18210741 15052691 16248980 17869086 17640975 12741479 12389079 18481824 18277467 15057751 12632514 18420326 12445421 17922224 17698563 16033810 18472332 15931870 18429990 16136751 16192424 12609069 12898905 16116963 17805973 16011737 15818738 16638106 16015684 17900296 10355542 15996030 17631135 11481614 18279442 17944888 12632512 18412020 17714472 14748882 17525996 16027843 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
9.64 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
9.64 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
9.64 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
9.64 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
9.64 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Thalidomide |
9.64 | 15465738 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
8.04 | 19784758 19460945 12969438 12587719 19014921 16611625 11587558 16610002 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
8.04 | 16964402 15830285 16246199 15720792 17285989 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
8.04 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
8.04 | 19363144 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.51 | 16737972 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.67 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
7.94 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
7.94 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
33.54 | 15890375 18177683 2125692 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
33.54 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
33.54 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
33.54 | 19499222 2422723 19996281 15175105 19638242 2862719 19073162 19690152 20492335 19850985 19427195 19254457 20137499 18978307 12771043 15885732 19833225 18754104 9163691 19551842 21047994 20452335 21278145 18648771 20405173 20118626 21167192 19090486 10737359 18644402 21071580 20501860 19255062 20434301 19256749 18977376 19642983 20101389 12112319 19426721 16942905 19294768 20583210 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
33.54 | 15113037 17045692 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
33.54 | 20302851 16640825 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
33.54 | 18709148 14757943 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
33.54 | 19482888 8742319 19812893 15975961 21047994 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
33.54 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
33.54 | 20405173 19073162 19321006 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
33.54 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
31.90 | 3712494 598648 1399818 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
31.90 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
31.90 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
31.90 | 17854601 19126423 21159647 18775883 16267830 19519916 19539802 18308698 18079962 3124819 19009564 17942915 19004024 18253720 2563599 18164116 9362446 18093689 17174075 18282651 18544905 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
31.90 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
31.90 | 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
31.90 | 17172636 2563599 6150874 1399818 18308698 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
31.90 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
31.90 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
3.03 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.74 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
7.79 | 18339021 |
MESH:D055370 |
Lung Injury |
|
Ozone |
7.79 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
16.10 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
16.10 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
16.10 | 20464547 18520028 17053015 18816296 6695378 18569708 20064080 20135361 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
16.10 | 20970405 6695378 21163286 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
16.10 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
16.10 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
16.10 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
16.10 | 9230183 20970405 10545420 16337739 11893704 16271038 20512841 15390079 1399818 6695378 21163286 17909032 7750092 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
16.10 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
16.10 | 19555203 11884234 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.28 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
6.65 | 12854902 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
6.65 | 16098063 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
8.92 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.92 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
17.31 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
17.31 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
17.31 | 14749477 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
17.31 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.07 | 15621674 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.69 | 16640825 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.74 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
23.32 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
23.32 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
23.32 | 17203775 11408345 11807958 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
23.32 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
23.32 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
23.32 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tocopherols |
23.32 | 17927505 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.96 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
8.61 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
8.61 | 12025231 16342250 12040289 |
MESH:D008545 |
Melanoma |
|
resveratrol |
8.61 | 17992120 |
MESH:D008545 |
Melanoma |
|
Thalidomide |
8.61 | 16098027 12829675 17089043 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
8.61 | 15577323 16809738 18332650 16432458 17761969 15577320 16248763 18176117 12374674 18505091 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
9.18 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
9.18 | 16388313 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
6.02 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Tocopherols |
6.02 | 15878867 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.92 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.27 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.59 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.82 | 18803445 18765137 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.04 | 15792986 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.56 | 19299654 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
7.22 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
7.22 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.28 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
14.36 | 19549372 18443271 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
14.36 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
14.36 | 16490592 16267019 17164350 17049120 17935668 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
Thalidomide |
14.36 | 15744524 15867202 16445831 19112201 15939924 17168659 19372569 19112817 15741222 15920492 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
5.15 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.36 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.01 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.57 | 8888407 |
MESH:D009181 |
Mycoses |
|
Iron |
4.95 | 16640825 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
10.80 | 17596541 19805378 17611569 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Thalidomide |
10.80 | 18720364 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
10.80 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
11.62 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
11.62 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
11.62 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
11.62 | 17125593 17188708 16456233 16525036 17015251 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
13.02 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
13.02 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
13.02 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
17.09 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
17.09 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
17.09 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
17.09 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.25 | 17322642 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
3.97 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
11.73 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
11.73 | 9029167 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
11.73 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
11.73 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
12.85 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
12.85 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
12.85 | 16928823 18239605 18600527 |
MESH:D009369 |
Neoplasms |
|
lycopene |
12.85 | 17051425 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
12.85 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
3.51 | 8985016 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.23 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.27 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.92 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
13.33 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
13.33 | 15640375 16889571 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
13.33 | 17178036 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.49 | 17356569 15790535 18619942 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
25.65 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
25.65 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
25.65 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
25.65 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Thalidomide |
25.65 | 16859833 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.11 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.11 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
6.27 | 15176712 8761367 16115947 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.27 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
16.71 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
16.71 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
16.71 | 17296847 16604332 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
16.71 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.38 | 8761367 12837982 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
3.93 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.60 | 20387270 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.09 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
8.20 | 8291058 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
8.20 | 17378895 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.46 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
3.93 | 18674790 16723640 19632207 20518802 21332399 20132043 11836018 17217161 18457598 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
3.93 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
2.98 | 6482804 4026338 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.21 | 16517039 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.50 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.65 | 16640825 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.47 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
3.86 | 17016548 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.41 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Iron |
6.41 | 16640825 16648989 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
8.60 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
8.60 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.71 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.48 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
13.00 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
13.00 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
13.00 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
13.00 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Thalidomide |
13.00 | 16288038 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.50 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
5.50 | 12161096 18093676 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
10.64 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
10.64 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
10.64 | 16500647 16929163 15113037 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
10.64 | 16965848 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.22 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
7.82 | 7296757 |
MESH:D010212 |
Papilloma |
|
Iron |
7.82 | 12065085 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.50 | 17352947 |
MESH:D010291 |
Paresis |
|
Thalidomide |
5.79 | 9200351 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
7.66 | 16640825 16563566 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
7.66 | 16702228 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
7.66 | 11445065 19232380 15451049 18619942 19114014 18191903 11535288 16412576 16140633 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.64 | 18197244 15927086 15574749 15795934 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.73 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.64 | 16369182 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
3.95 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.64 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
5.15 | 16604332 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.64 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
3.89 | 18381685 18929643 18007984 |
MESH:D011041 |
Poisoning |
|
Iron |
3.83 | 16604332 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
9.42 | 16640825 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
9.42 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
12.79 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
12.79 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
12.79 | 2563599 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
11.00 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
11.00 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Thalidomide |
11.00 | 17031469 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
4.03 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
25.09 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
25.09 | 17132714 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
25.09 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
25.09 | 11118676 11399792 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
25.09 | 20603192 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.04 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.04 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
8.31 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
8.31 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
8.31 | 18487222 17914592 19011039 19240160 15638997 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
8.31 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
8.31 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
8.31 | 15897917 15749863 18437689 16888761 16729912 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
8.31 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
8.31 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
8.31 | 15256057 15378649 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
8.31 | 17337101 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
8.31 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
8.31 | 16356831 17172428 16729912 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
8.31 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
8.31 | 17675339 17636462 17718901 17804756 16731767 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
Thalidomide |
8.31 | 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tocopherols |
8.31 | 12504091 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.50 | 16640825 |
MESH:D011536 |
Prurigo |
|
Thalidomide |
5.79 | 12755975 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.81 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
10.47 | 12752131 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
10.47 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.03 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.28 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.07 | 16636934 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.58 | 18722050 16160472 18286688 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.73 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.06 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.67 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.67 | 16317513 16314181 17520802 15827377 17058453 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
4.04 | 18339021 17627322 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.35 | 18990726 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
4.16 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
2.99 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
3.71 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.66 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.55 | 18313854 15675481 17710206 17203757 16767912 15625365 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
3.76 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.28 | 17846226 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
1.99 | 15737665 19110320 |
MESH:D019873 |
Schnitzler Syndrome |
|
Thalidomide |
5.43 | 16096327 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.35 | 16636934 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
4.84 | 4039156 3137016 16876388 11442880 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
4.84 | 11044598 16876388 17978042 14763951 3137016 15475178 1511512 11738929 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.31 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
15.16 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
15.16 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
15.16 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
15.16 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
15.16 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.07 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.42 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.00 | 16517039 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
3.77 | 15862959 16503802 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.39 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.02 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.21 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
4.21 | 18456281 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
4.21 | 19084572 18396642 16951190 19015929 15786421 18567086 17498489 17522103 17172411 16424979 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
4.21 | 18396642 18506536 |
MESH:D013276 |
Stomach Ulcer |
|
Thalidomide |
3.74 | 15138204 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.04 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.48 | 16045194 16684133 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
11.63 | 16640825 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
11.63 | 12563064 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.55 | 12837982 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.30 | 16930453 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.15 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.73 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.38 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
13.91 | 3712494 1399818 6582329 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
13.91 | 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
13.91 | 16010429 17909728 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
13.91 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.17 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.52 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.52 | 16227395 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.71 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Iron |
3.76 | 16597321 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.01 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.10 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
10.10 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
10.10 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
10.10 | 17653716 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.15 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.51 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
8.14 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.14 | 17473185 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.49 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
13.37 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
13.37 | 17044934 |
MESH:D014594 |
Uterine Neoplasms |
|
sulindac sulfide |
13.37 | 18645019 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.47 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
4.55 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
Thalidomide |
4.97 | 15741222 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.08 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.08 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
8.69 | 17678736 16364871 17334414 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.69 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.73 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.31 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.92 | 17120751 |